Tuesday, April 22, 2014

Reuters: Sarepta shares soar on new hope for fatal muscle disorder drug

(Reuters) - Sarepta Therapeutics Inc's shares soared 64 percent after it said that the U.S. Food and Drug Administration indicated an alternate path to approval for the company's experimental muscle disorder drug. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/cVDzZE_ewww/story01.htm

Read More
Posted by at

1 comment:

  1. protein tozuApril 24, 2014 at 5:23 AM

    i think your blog very informative, thanks for sharing.

    ReplyDelete

Subscribe to: Post Comments (Atom)

Subscribe Now: Feed Icon

Subscribe in a reader